Home > Boards > US OTC > Biotechs > Revance Therapeutics, Inc. (RVNC)

Another positive - all RVNC directors, etc. acquired

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
floblu14 Member Profile
 
Followed By 21
Posts 3,603
Boards Moderated 0
Alias Born 07/20/06
160x600 placeholder
Revance to Showcase Data from Phase 3 ASPEN-1 Clinical Trial Evaluating Efficacy, Duration of Effect and Safety of DaxibotulinumtoxinA for Injection for Cervical Dystonia at International Parkinson and Movement Disorder Society Virtual Congress 2021 Business Wire - 9/16/2021 8:00:00 AM
Revance Presents Data on the RHA® Collection of Dermal Fillers at the 2021 Virtual Skin of Color Update Meeting Business Wire - 9/10/2021 8:00:00 AM
Revance to Participate in the Wells Fargo Securities Healthcare Conference Business Wire - 9/2/2021 8:00:00 AM
Revance Announces Publication of Results on Static Glabellar Lines With Repeated Treatment of DaxibotulinumtoxinA for Injection From the SAKURA Clinical Program in Dermatologic Surgery Business Wire - 9/1/2021 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/17/2021 6:20:51 PM
Revance Therapeutics EPS beats by $0.06, beats on revenue Seeking Alpha - 8/5/2021 5:12:42 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/5/2021 4:42:38 PM
Revance Reports Second Quarter 2021 Financial Results, Provides Corporate Update Business Wire - 8/5/2021 4:05:00 PM
Revance to Release Second Quarter 2021 Financial Results on Thursday, August 5, 2021 Business Wire - 7/29/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/6/2021 4:34:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2021 7:56:50 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2021 7:54:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2021 7:52:54 PM
Revance to Participate in Upcoming Virtual Healthcare Conferences Business Wire - 5/26/2021 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/26/2021 8:04:50 AM
Revance Provides Update on DaxibotulinumtoxinA for Injection Pre-Approval Inspection Business Wire - 5/26/2021 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2021 4:42:24 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/10/2021 4:11:10 PM
Revance Therapeutics EPS beats by $0.11, beats on revenue Seeking Alpha - 5/10/2021 4:10:14 PM
Revance Reports First Quarter 2021 Financial Results, Provides Corporate Update Business Wire - 5/10/2021 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/7/2021 7:15:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/7/2021 7:13:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/7/2021 7:11:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/7/2021 7:09:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/7/2021 7:07:11 PM
floblu14   Saturday, 05/08/21 07:27:29 AM
Re: None
Post # of 2120 
Another positive - all RVNC directors, etc. acquired & HELD. Just the opposite of my Momenta Pharma where Craig, Young, Tony Manning et al disposed of their grants before the ink dried! Matter-of-fact, Tony "my hero" sold all his shares post haste thinking that the J&J buyout was kaput. LOL

RVNC -
1. SEC Form 4: Gangolli Julian S was granted 4,013 units of Common Stock, increasing direct ownership by 24% to 20,513 units
quantisnow.com/insight/7189...
2. SEC Form 4: Kolaja Carey OConnor was granted 674 units of Common Stock, increasing direct ownership by 11% to 6,968 units
quantisnow.com/insight/7189...
3. SEC Form 4: Nolet Chris was granted 4,013 units of Common Stock, increasing direct ownership by 27% to 19,013 units
quantisnow.com/insight/7189...
4. SEC Form 4: Russell Angus C. was granted 4,013 units of Common Stock, increasing direct ownership by 24% to 20,513 units
quantisnow.com/insight/7189...
5. SEC Form 4: Vickers Philip J. was granted 4,013 units of Common Stock, increasing direct ownership by 20% to 23,663 units
quantisnow.com/insight/7189...
6. SEC Form 4: Ware Olivia C was granted 674 units of Common Stock, increasing direct ownership by 11% to 7,082 units
quantisnow.com/insight/7189...

+ others HELD.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences